Literature DB >> 19995748

Treg and lupus.

M Bonelli1, J S Smolen, C Scheinecker.   

Abstract

Autoimmune diseases such as systemic lupus erythemathodes (SLE) display quantitative and/or qualitative deficiencies of CD4+CD25+ regulatory T cells (Treg). This might contribute to the immune dysregulation and break-down of peripheral tolerance mechanisms. In addition novel subsets of Treg might arise under specific autoimmune conditions as an effort to counteract autoimmunity. Advances in our understanding of how to characterise and manipulate Treg in patients with autoimmune diseases are required in order to develop new therapeutic strategies.

Entities:  

Mesh：

Year:  2010        PMID： 19995748     DOI： 10.1136/ard.2009.117135

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  27 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

2.  The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study.

Authors:  Antonella Afeltra; Antonietta Gigante; Domenico Paolo Emanuele Margiotta; Chiara Taffon; Rosario Cianci; Biagio Barbano; Marta Liberatori; Antonio Amoroso; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2015-02-27       Impact factor: 3.397

3.  Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis.

Authors:  Shilpy Sharma; So Watanabe; Anita Sivam; JiangHong Wang; Samantha J Neuwirth; Rosanne I Perez; Marcella De Tineo; Fuad M Baroody; Robert M Naclerio; Jayant M Pinto
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

4.  Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis.

Authors:  Ethan J Baughman; Jason P Mendoza; Sterling B Ortega; Chris L Ayers; Benjamin M Greenberg; Elliot M Frohman; Nitin J Karandikar
Journal:  J Autoimmun       Date:  2011-01-22       Impact factor: 7.094

5.  Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice.

Authors:  Hao Wu; Yuxin Chen; Hong Liu; Lin-Lin Xu; Paula Teuscher; Shixia Wang; Shan Lu; Alexander L Dent
Journal:  Eur J Immunol       Date:  2016-03-11       Impact factor: 5.532

6.  Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia.

Authors:  Kristin Palmsten; Sonia Hernández-Díaz; Bindee Kuriya; Daniel H Solomon; Soko Setoguchi
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

Review 7.  Update on cardiovascular disease in lupus.

Authors:  Laura B Lewandowski; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

8.  CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.

Authors:  Tomohiro Koga; Christian M Hedrich; Masayuki Mizui; Nobuya Yoshida; Kotaro Otomo; Linda A Lieberman; Thomas Rauen; José C Crispín; George C Tsokos
Journal:  J Clin Invest       Date:  2014-03-25       Impact factor: 14.808

9.  Significant association of CD4+CD25+Foxp3+ regulatory T cells with clinical findings in patients with systemic lupus erythematosus.

Authors:  Xiaofan Yang; Weiwen Wang; Juan Xu; Ming-Shun Zhang; Huanping Mei; Youxuan Shen; Miao-Jia Zhang; Xiaohui Ji; Huijuan Wang
Journal:  Ann Transl Med       Date:  2019-03

Review 10.  Leptin: an unappreciated key player in SLE.

Authors:  Qihang Yuan; Haifeng Chen; Xia Li; Jing Wei
Journal:  Clin Rheumatol       Date:  2019-11-09       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.